Nufarm HY26 results presentation

• Improved earnings and cash flow, reduced leverage
• Reaffirmed FY26 outlook for uEBITDA and leverage
• Strong first half results with increased revenue and uEBITDA
• Focus on profitable growth, disciplined capital allocation
• Strategic partnership with bp and reduced cash costs in omega-3

Nufarm Ltd. has released its half-year financial results for FY26, showing improved earnings and cash flow, as well as reduced leverage. The company reaffirmed its outlook for FY26, targeting uEBITDA and leverage. Nufarm achieved strong first half results with a 5% increase in revenue and a 35% increase in uEBITDA year-on-year. The company is focusing on profitable growth, disciplined capital allocation, and strategic partnerships, particularly with bp, to reduce cash costs in omega-3. Nufarm is also prioritizing its seeds platforms for growth and capital deployment, with a disciplined investment approach for emerging platforms.

FY26/27 Targets: $50m cost savings, Capex <$200m, Leverage ~2.0x

Nufarm expects its strategy to deliver improved profitability, higher returns, and cash generation. The company plans to sustain capex at a similar level to FY26, aiming for positive free cash flow and ROFE > cost of capital on average through the cycle.